[Substitution of F XIII concentrate in ulcerative colitis]

Z Gastroenterol. 1989 Feb;27(2):87-90.
[Article in German]

Abstract

A 33 years old female with ulcerative colitis was admitted with an acute exacerbation of the disease characterised by haematochezia, diarrhoea (10 stools/die) and anaemia (haemoglobin 6.5 g/dl). Therapy with 5-ASA and corticosteroids for six weeks failed to decrease the activity of the disease. Since deficiency of coagulation factor XIII (activity 60%, subunit A 56%) was present, in addition, concentrates of factor XIII (Fibrogammin HS, Behring, F.R.G.) 1250 U/die were given for ten days. The substitution resulted in an immediate increase of reduced F XIII activity (164%) and F XIII subunit A (333%) as well as in a marked improvement of symptoms.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Adult
  • Blood Coagulation Tests
  • Colitis, Ulcerative / diagnosis
  • Colitis, Ulcerative / therapy*
  • Combined Modality Therapy
  • Factor XIII / therapeutic use*
  • Factor XIII Deficiency / diagnosis
  • Factor XIII Deficiency / therapy*
  • Female
  • Follow-Up Studies
  • Humans
  • Ultrasonography

Substances

  • Factor XIII